Department of Biological Sciences, The University of Texas at Dallas, Dallas, TX, 75080, United States.
Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, 10051, Taiwan.
Int J Biochem Cell Biol. 2021 Feb;131:105905. doi: 10.1016/j.biocel.2020.105905. Epub 2020 Dec 24.
Beyond its well-known canonical function as a tumor suppressor, p53 is also involved in numerous cellular processes through altered transcription under both normal and pathological conditions. The functional diversity of p53 outputs is complex and dependent on cell context. However, the underlying mechanisms responsible for this diversity remain largely unclear. The emerging evidence of p53 mutations involved in regulating endocytic trafficking and signaling, in tandem to promote malignancy (invasion, exosome biogenesis and immune evasion), sheds light on possible mechanisms behind the p53-driven complexity. The interrelated nature of endocytic trafficking and receptor signaling that form dynamic and adaptable feedback loops - either positive or negative - functions to modulate multiple cellular outputs. Biasing the tunable endocytic trafficking and receptor signaling network by mutant p53 expands the purview of p53, allowing its contribution to diverse and aggressive phenotypes. In this review, we explore recent studies in which the novel role of mutant p53 in altering endocytic trafficking to bias receptor signaling and drive transforming phenotypes is revealed. Understanding the complex crosstalk of mutant p53, endocytic trafficking and receptor signaling will allow the development of therapies to selectively target p53-altered endocytic processes.
除了作为肿瘤抑制因子的众所周知的经典功能外,p53 在正常和病理条件下通过转录改变也参与了许多细胞过程。p53 输出的功能多样性很复杂,并且依赖于细胞环境。然而,导致这种多样性的潜在机制在很大程度上仍不清楚。p53 突变参与调节内吞作用和信号转导,以促进恶性肿瘤(侵袭、外泌体发生和免疫逃避)的新兴证据,揭示了 p53 驱动的复杂性背后的可能机制。内吞作用和受体信号转导的相互关联性质形成了动态和适应性的反馈环——无论是正反馈还是负反馈——有助于调节多种细胞输出。突变型 p53 通过改变内吞作用和受体信号转导网络的可调性,扩大了 p53 的作用范围,使其能够促进多种侵袭性表型的发生。在这篇综述中,我们探讨了最近的研究,揭示了突变型 p53 在改变内吞作用以偏向受体信号转导并驱动转化表型方面的新作用。了解突变型 p53、内吞作用和受体信号转导的复杂串扰将有助于开发选择性靶向 p53 改变的内吞过程的治疗方法。